Research facility · founded 1955
Friends Research Institute
Baltimore, United States · friendsresearch.org
- Citations, last 5 years
- 2 249
- Works, last 5 years
- 337
- h-index
- 125
- Scientists listed
- 18
- Grants since 2016
- 82
Grants received
2019–2024 · research · R01
Opioid Use Disorder Treatment Linkage at STD Clinics using Buprenorphine (OUTLAST-B)
Jan Gryczynski · Friends Research Institute · funded by National Institutes of Health
2019–2024 · research · R01
Opioid Use Disorder Treatment Linkage at STD Clinics using Buprenorphine (OUTLAST-B)
Jan Gryczynski · Friends Research Institute · funded by National Institutes of Health
2019–2026 · research · R01
Opioid Use Disorder Treatment Linkage at STD Clinics using Buprenorphine (OUTLAST-B)
Jan Gryczynski · Friends Research Institute · funded by National Institutes of Health
2019–2021 · research · R21
People Preferring Fentanyl (PPF): Characteristics, Outcomes, and Perspectives
Jan Gryczynski · Friends Research Institute · funded by National Institutes of Health
2019–2023 · research · R21
People Preferring Fentanyl (PPF): Characteristics, Outcomes, and Perspectives
Jan Gryczynski · Friends Research Institute · funded by National Institutes of Health
2019–2024 · cooperative agreement · UG1
A comparative effectiveness trial of extended release naltrexone versus extended-release buprenorphine with individuals leaving jail
Michael Scott Gordon · Friends Research Institute · funded by National Institutes of Health
2019–2024 · cooperative agreement · UG1
A comparison of Sublingual and Extended-Release Buprenorphine for Individuals Leaving Jail
Michael Scott Gordon · Friends Research Institute · funded by National Institutes of Health
2019–2025 · research · R01
Opioid Use Disorder Treatment Linkage at STD Clinics using Buprenorphine (OUTLAST-B)
Jan Gryczynski · Friends Research Institute · funded by National Institutes of Health
2019–2024 · cooperative agreement · UG1
A comparative effectiveness trial of extended release naltrexone versus extended-release buprenorphine with individuals leaving jail
Michael Scott Gordon · Friends Research Institute · funded by National Institutes of Health
2019–2024 · cooperative agreement · UG1
A comparative effectiveness trial of extended release naltrexone versus extended-release buprenorphine with individuals leaving jail
Michael Scott Gordon · Friends Research Institute · funded by National Institutes of Health
2019–2026 · cooperative agreement · UG1
A comparative effectiveness trial of extended release naltrexone versus extended-release buprenorphine with individuals leaving jail
Thomas Blue · Friends Research Institute · funded by National Institutes of Health
2018–2024 · research · R01
Buprenorphine for probationers and parolees: Bridging the gap into treatment
Michael Scott Gordon · Friends Research Institute · funded by National Institutes of Health
2018–2023 · research · R01
Buprenorphine for probationers and parolees: Bridging the gap into treatment
Michael Scott Gordon · Friends Research Institute · funded by National Institutes of Health
2018
Embedding smoking cessation programs into community clinics
Theodore Friedman · Friends Research Institute · funded by Office of the President, University of California
2018–2023 · research · R01
Getting Off: A Theory-based mHealth Intervention for Methamphetamine-using MSM
Cathy J Reback · Friends Research Institute · funded by National Institutes of Health
2018–2024 · research · R01
Getting Off: A Theory-based mHealth Intervention for Methamphetamine-using MSM
Cathy J Reback · Friends Research Institute · funded by National Institutes of Health
2018–2022 · cooperative agreement · U01
Addiction Medicine Practice Based Research Network (AMNet): Addressing the Opioid Crisis
Robert P Schwartz · Friends Research Institute · funded by National Institutes of Health
2018–2023 · research · R01
Buprenorphine for probationers and parolees: Bridging the gap into treatment
Michael Scott Gordon · Friends Research Institute · funded by National Institutes of Health
2018–2023 · cooperative agreement · U01
Facilitating the Implementation of Interim Methadone to Increase Treatment Access: A Multi-Site Implementation Trial
Robert P Schwartz · Friends Research Institute · funded by National Institutes of Health
2018–2023 · research · R01
Getting Off: A Theory-based mHealth Intervention for Methamphetamine-using MSM
Cathy J Reback · Friends Research Institute · funded by National Institutes of Health
2018–2026 · research · R01
Buprenorphine for probationers and parolees: Bridging the gap into treatment
Michael Scott Gordon · Friends Research Institute · funded by National Institutes of Health
2018–2022 · cooperative agreement · U01
Facilitating the Implementation of Interim Methadone to Increase Treatment Access: A Multi-Site Implementation Trial
Robert P Schwartz · Friends Research Institute · funded by National Institutes of Health
2018–2022 · cooperative agreement · U01
Facilitating the Implementation of Interim Methadone to Increase Treatment Access: A Multi-Site Implementation Trial
Robert P Schwartz · Friends Research Institute · funded by National Institutes of Health
2018–2023 · research · R01
Getting Off: A Theory-based mHealth Intervention for Methamphetamine-using MSM
Cathy J Reback · Friends Research Institute · funded by National Institutes of Health
2018–2023 · research · R01
Buprenorphine for probationers and parolees: Bridging the gap into treatment
Michael Scott Gordon · Friends Research Institute · funded by National Institutes of Health
2018–2022 · cooperative agreement · U01
Facilitating the Implementation of Interim Methadone to Increase Treatment Access: A Multi-Site Implementation Trial
Robert P Schwartz · Friends Research Institute · funded by National Institutes of Health
2018–2022 · cooperative agreement · U01
Facilitating the Implementation of Interim Methadone to Increase Treatment Access: A Multi-Site Implementation Trial
Robert P Schwartz · Friends Research Institute · funded by National Institutes of Health
2018–2023 · research · R01
Buprenorphine for probationers and parolees: Bridging the gap into treatment
Michael Scott Gordon · Friends Research Institute · funded by National Institutes of Health
2018–2024 · research · R01
Buprenorphine for probationers and parolees: Bridging the gap into treatment
Michael Scott Gordon · Friends Research Institute · funded by National Institutes of Health
2018–2022 · cooperative agreement · U01
Facilitating the Implementation of Interim Methadone to Increase Treatment Access: A Multi-Site Implementation Trial
Robert P Schwartz · Friends Research Institute · funded by National Institutes of Health
2018–2023 · research · R01
Getting Off: A Theory-based mHealth Intervention for Methamphetamine-using MSM
Cathy J Reback · Friends Research Institute · funded by National Institutes of Health
2018–2023 · grant · Community Practice-Based Research Implementation Award
Embedding smoking cessation programs into community clinics
Theodore Friedman · Friends Research Institute · funded by Office of the President, University of California
2016–2025 · research · R01
Long-acting naltrexone for pre-release prisoners: A randomized trial of mobile treatment
Michael Scott Gordon · Friends Research Institute · funded by National Institutes of Health
2016–2022 · research · R01
Long-acting naltrexone for pre-release prisoners: A randomized trial of mobile treatment
Michael Scott Gordon · Friends Research Institute · funded by National Institutes of Health
2016–2019 · research · R21
Next Gen NRT pharmacokinetics and pharmacodynamics
Frank J. Vocci · Friends Research Institute · funded by National Institutes of Health
2016–2018 · research · R21
Next Gen NRT pharmacokinetics and pharmacodynamics
Frank J. Vocci · Friends Research Institute · funded by National Institutes of Health
2016–2021 · research · R01
Long-acting naltrexone for pre-release prisoners: A randomized trial of mobile treatment
Michael Scott Gordon · Friends Research Institute · funded by National Institutes of Health
2016–2022 · research · R01
Long-acting naltrexone for pre-release prisoners: A randomized trial of mobile treatment
Michael Scott Gordon · Friends Research Institute · funded by National Institutes of Health
2016–2020 · research · LJAF
Friends Research Institute Inc
Friends Research Institute · funded by Arnold Ventures
2016–2021 · research · R01
Long-acting naltrexone for pre-release prisoners: A randomized trial of mobile treatment
Michael Scott Gordon · Friends Research Institute · funded by National Institutes of Health